Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douketis

Showing results (41-50 of 425) with videos related to

Pageof 43
Sort By:
Evidence-Based Medicine|August 4, 2009
The devil is in the details...or not? A primer on individual patient data meta-analysisSachin Sud, James Douketis
Internal and Emergency Medicine|June 29, 2013
Perioperative management of patients who are receiving a novel oral anticoagulantAaron Liew, James Douketis
Heart (British Cardiac Society)|December 9, 2017
Perioperative management of anticoagulant and antiplatelet therapyAlfonso Tafur, James Douketis
Polskie Archiwum Medycyny Wewnetrznej|November 23, 2016
Periprocedural risk of bleeding and thrombosis: to bridge or not to bridge. Dr. James Douketis in an interview with Dr. Roman Jaeschke: part 2James Douketis, Roman Jaeschke
Journal of Thrombosis and Haemostasis : JTH|July 8, 2015
Journal of Thrombosis and Haemostasis. Special Issue: State of the Art 2015. PrefaceDavid Lillicrap, Jim Douketis
Annals of Internal Medicine|September 23, 2016
4 risk assessment models had good calibration but poor discrimination for VTE in hospitalized medical patientsAaron Liew, James Douketis
ACP Journal Club|March 6, 2007
Persistent right ventricular dysfunction increased risk for recurrent venous thromboembolism after acute pulmonary embolismJames Douketis, Scott Kaatz
Annals of Internal Medicine|June 18, 2019
In high-risk patients with cancer, thromboprophylaxis with rivaroxaban did not reduce VTE events at 180 daysAndrea Cervi, James Douketis
Annals of Internal Medicine|July 31, 2023
In AF, the effects of DOACs vs. warfarin on death and stroke/systemic embolism vary by baseline CrCl levelStephanie Carlin, James Douketis
European Journal of Internal Medicine|February 7, 2021
Postoperative atrial fibrillation after non-cardiac surgery: How important is it and what do we do about it?Michael Ke Wang, James Douketis
Pageof 43

Showing results (41-50 of 425) with videos related to

Sort By:
Pageof 43
Evidence-Based Medicine|August 4, 2009
The devil is in the details...or not? A primer on individual patient data meta-analysisSachin Sud, James Douketis
Internal and Emergency Medicine|June 29, 2013
Perioperative management of patients who are receiving a novel oral anticoagulantAaron Liew, James Douketis
Heart (British Cardiac Society)|December 9, 2017
Perioperative management of anticoagulant and antiplatelet therapyAlfonso Tafur, James Douketis
Polskie Archiwum Medycyny Wewnetrznej|November 23, 2016
Periprocedural risk of bleeding and thrombosis: to bridge or not to bridge. Dr. James Douketis in an interview with Dr. Roman Jaeschke: part 2James Douketis, Roman Jaeschke
Journal of Thrombosis and Haemostasis : JTH|July 8, 2015
Journal of Thrombosis and Haemostasis. Special Issue: State of the Art 2015. PrefaceDavid Lillicrap, Jim Douketis
Annals of Internal Medicine|September 23, 2016
4 risk assessment models had good calibration but poor discrimination for VTE in hospitalized medical patientsAaron Liew, James Douketis
ACP Journal Club|March 6, 2007
Persistent right ventricular dysfunction increased risk for recurrent venous thromboembolism after acute pulmonary embolismJames Douketis, Scott Kaatz
Annals of Internal Medicine|June 18, 2019
In high-risk patients with cancer, thromboprophylaxis with rivaroxaban did not reduce VTE events at 180 daysAndrea Cervi, James Douketis
Annals of Internal Medicine|July 31, 2023
In AF, the effects of DOACs vs. warfarin on death and stroke/systemic embolism vary by baseline CrCl levelStephanie Carlin, James Douketis
European Journal of Internal Medicine|February 7, 2021
Postoperative atrial fibrillation after non-cardiac surgery: How important is it and what do we do about it?Michael Ke Wang, James Douketis
Pageof 43